RVNC

Revance Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD3.65

+0.00 (+0.00%)

CEO

Mark J. Foley

IPO Date

2014-02-06

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

Open

$3.65

Prev. Close

$3.65

Day Low

$3.65

Day High

$3.65

52W Low

$2.30

52W High

$7.56

Market Cap

$0.38B

News SentimentNeutral

Articles

Avg Positive

29.4%

Avg Negative

29.4%

Avg Neutral

41.1%

News Feed

Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q1 2021 Results - Earnings Call Transcript

Recap: Revance Therapeutics Q1 Earnings

Revance to Participate in the 20th Annual Needham Virtual Healthcare Conference